CONGRESSWOMAN ELISE STEFANIK
On Tuesday, November 12, 2013, the House will consider S. 330, the HIV Organ Policy Equity Act, under a suspension of the rules. The bill was introduced on February 14, 2013, by Sen. Barbara Boxer (D-CA) and passed in the Senate by unanimous consent. S. 330 was received in the House and referred to the House Energy and Commerce Committee. The bill was also referred to the Committee on the Judiciary, which waived consideration.
The HOPE Act allows research to fully evaluate the safety and efficacy of organ transplantation between individuals with Human Immunodeficiency Virus (HIV). In 1984, Congress enacted the National Organ Transplant Act (NOTA). The purpose of NOTA was to guide organ donation and transplantation. In 1988, Congress amended NOTA to ban the transplantation of HIV-infected organs. Today, HIV treatments have extended and improved the lives of individuals with HIV. This in turn has increased the need for organ donations.
S. 330 permits research on transplants involving HIV-positive individuals by eliminating the restriction on acquiring HIV-positive organs. The legislation also directs the Secretary of HHS to develop and implement standards for research on the transplantation of HIV-infected organs. In addition, the bill requires the Secretary of HHS to revise transplant standards based on the research.
Finally, it amends the federal criminal code to declare that an organ donation does not violate the prohibition against a knowing organ donation by an HIV-infected individual if the donation is made in accordance with this Act.
H.R. 698, the House companion bill to this legislation, passed in the House Energy and Commerce Committee by unanimous consent.
CBO estimates that implementation of S. 330 would result in administrative costs of less than $500,000 annually and about $1 million over the 2014-2018 period. The bill would not authorize new funds.
For questions or further information contact the GOP Conference at 5-5107.